Etoricoxib: Clinical Trials

111 trials of Etoricoxib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 completed, 14 unknown, 6 withdrawn, 5 terminated. 35 Phase 4, 33 Phase 3, 15 Phase 2, 12 Not applicable, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 435Completed 20, Unknown 8, Withdrawn 4, Terminated 2, Not yet recruiting 1
Phase 333Completed 29, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 215Completed 8, Unknown 3, Terminated 2, Recruiting 1, Withdrawn 1
Not applicable12Completed 11, Unknown 1
Phase 111Completed 9, Active not recruiting 1, Unknown 1
Early Phase 11Unknown 1

Follow Etoricoxib: new trials by email Literature Review of Etoricoxib trials Research Report on Etoricoxib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time
Dotinurad, colchicine, etoricoxib - Gout
Phase 4Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University1422026-07-302026-06-22
Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil
FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo, etoricoxib 90 mg (Arcoxia®) +FDC placebo, cyclobenzaprine hydrochloride + etoricoxib placebo - Third Molar Extraction
Phase 3WithdrawnEurofarma Laboratorios S.A.2026-05-302024-02-28
Etoricoxib in Patients With Parkinsonian Disease
L-dopa, Etoricoxib - Parkinson Disease
Phase 2RecruitingIhab Elsayed Hassan602026-01-302026-04-08
Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
Nerve Block, endoscopic spinal disecetomy, Medication - Chronic Low Back Pain (CLBP), Acute Low Back Pain
Not yet recruitingPeking University Third Hospital3602025-05-152025-05-13
Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis
Fixed Dose Etoricoxib + Betamethasone, Monotherapy Etoricoxib - Bursitis, Tendinitis
Phase 3CompletedLaboratorios Silanes S.A. de C.V.892025-05-142026-01-08
Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain
Celecoxib, Etoricoxib (Treatment Group) - Orthodontic Pain (D013850)
Phase 1Active not recruitingSharif Medical Research Center1502025-05-082026-04-30
Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
Etoricoxib + Betamethasone fixed dose, Etoricoxib fixed dose - Gout Arthritis, Gout Attack
Phase 3RecruitingLaboratorios Silanes S.A. de C.V.722025-01-272025-04-03
Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm
Etoricoxib + Tizanidine fixed dose, Etoricoxib fixed dose - Acute Low-back Pain, Muscle Spasm; Back Pain
Phase 3CompletedLaboratorios Silanes S.A. de C.V.1362024-09-182026-01-09
The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination
etoricoxib 60mg - Back Pain Lower Back Chronic
Phase 4UnknownMuhammad Ilyas1402024-06-012024-05-13
Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis.
Etoricoxib 90 mg + diacerein 50 mg, Meloxicam 15 mg + diacerein 50 mg - Pain Management, Osteoarthritis
Phase 3CompletedLaboratorios Liomont1232024-05-242026-04-29
Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain
Etoricoxib + Cyanocobalamin fixed dose, Etoricoxib fixed dose - Acute Low-back Pain
Phase 3CompletedLaboratorios Silanes S.A. de C.V.1902024-04-262024-11-27
Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis
cheek acupuncture, Etoricoxib - Acute Gout Arthritis, Acupuncture
Not applicableCompletedGuangdong Provincial Hospital of Traditional Chinese Medicine762023-09-012024-07-18
Comparative Bioavailability Study Between Etoricoxib / Betamethasone Administered Individually or in Combination
A1: Etoricoxib / Betamethasone in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.), A2: Etoricoxib (Arcoxia®, Laboratorios Schering-Plough, S.A. de C.V.), A3: Betamethasone (Celestone® Pediatric, Laboratorios Schering-Plough, S.A. de C.V.) - Healthy
Phase 1CompletedLaboratorios Silanes S.A. de C.V.422022-10-242026-03-06
Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib
Dexamethasone, Etoricoxib 60 mg - Effect of Drug
Early Phase 1UnknownDow University of Health Sciences1702022-01-012021-12-16
Biomarkers for Prediction of Analgesic Efficacy in Knee OA.
Duloxetine 60mg, Etoricoxib 60 mg, omeprazol - Knee, Osteoarthritis (OA), Biomarkers for Prediction of OA Treatment Efficacy
Not applicableCompletedRambam Health Care Campus172021-12-302024-04-12
Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain
Etoricoxib 90 mg / Tramadol 50 mg, Acetaminophen 325 mg / Tramadol 37.5 mg - Acute Low Back Pain
Phase 3CompletedLaboratorios Silanes S.A. de C.V.1242021-11-292022-04-13
Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery
Etoricoxib 90 Mg Oral Tablet, Dexamethasone 4mg - Surgical Wound, Post Operative Pain
Phase 4CompletedUniversity of Belgrade902021-10-112023-03-30
Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers
Exib 120 mg etoricoxib film-coated tablets, Arcoxia® 120 mg etoricoxib film-coated tablets - Bioequivalence, Healthy Subjects
Phase 1CompletedDarnitsa Pharmaceutical Company282021-02-242024-11-29
Bioequivalence Study of Etoricoxib in Healthy Adult Subjects Under Fasting Condition
Etoricoxib 90 mg film coated tablet, Arcoxia 90 mg film coated tablet - Healthy Subjects
Phase 1CompletedFuture University in Egypt302020-12-282022-09-08
Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination
A1: Etoricoxib / Tramadol Fixed dose combination, A2: Etoricoxib, A3: Tramadol - Healthy
Phase 1CompletedLaboratorios Silanes S.A. de C.V.422020-08-032022-09-09

Showing 20 of 111. Sign in to see all of them.

Conditions studied

Osteoarthritis (18)  ·  Pain, Postoperative (16)  ·  Pain (15)  ·  Arthritis, Rheumatoid (7)  ·  Low Back Pain (5)  ·  Spondylitis, Ankylosing (5)  ·  Acute Pain (4)  ·  Osteoarthritis, Knee (4)  ·  Agnosia (3)  ·  Anterior Cruciate Ligament Injuries (2)  ·  Arthritis, Gouty (2)  ·  Back Pain (2)  ·  Bursitis (2)  ·  Chronic Pain (2)  ·  Dysmenorrhea (2)

Sponsors

Organon and Co (33)  ·  Laboratorios Silanes S.A. de C.V. (7)  ·  Chung Shan Medical University (2)  ·  Foisor Orthopedics Clinical Hospital (2)  ·  Karolinska Institutet (2)  ·  Meir Medical Center (2)  ·  University of Regensburg (2)  ·  Analgesic Solutions (1)  ·  Anne Margarita Dyrhol Riise (1)  ·  Argentine Tennis Association (1)  ·  Asker & Baerum Hospital (1)  ·  Azienda Sanitaria Locale 4, Teramo (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Barbro Dahlen (1)  ·  BioElectronics Corporation (1)

Countries

Mexico (8)  ·  Germany (7)  ·  Israel (6)  ·  Norway (5)  ·  Brazil (4)  ·  China (4)  ·  Sweden (3)  ·  Denmark (2)  ·  Egypt (2)  ·  Thailand (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Estonia (1)  ·  Finland (1)

Top investigators

Adelfia Urenda Quezada, M.D (1)  ·  Adelfia Urenda-Quezada, MD (1)  ·  Albrecht Reichle, Professor (1)  ·  Aleksa B Markovic (1)  ·  Alessandra Reis, doctor (1)  ·  Anne Holmberg, MD (1)  ·  Anne Margarita Dyrhol-Riise, PhD (1)  ·  Asokumar Buvanendran, MD (1)  ·  Boonsin Tangtrakulwanich, MD.,Ph.D (1)  ·  Brian Clausen, PT, M.Sc. (1)  ·  Carlos Alberto Montilla Morales, PhD/MD (1)

Results publications

PMID 19606021, PMID 11873051, PMID 12204484, PMID 15596866, PMID 16321158, PMID 17588299, PMID 188426, PMID 19363967, PMID 20039959, PMID 20052461, PMID 20536599, PMID 20973952, PMID 21848948, PMID 21905970, PMID 22337568, PMID 22738802, PMID 23359100, PMID 23371755, PMID 23703420, PMID 24150982, PMID 24156640, PMID 24481580, PMID 24960147, PMID 25133963, PMID 25399048, PMID 25886874, PMID 27454662, PMID 27502582, PMID 27737664, PMID 27836677, PMID 28464042, PMID 28778815, PMID 29107059, PMID 30888024, PMID 32472958, PMID 32797734, PMID 34811370, PMID 35365187, PMID 35724467, PMID 36633115, PMID 37452140, PMID 37721470, PMID 39256291, PMID 8951927

NIH funding

2009 (2), 2004 (1), 2005 (1), 2014 (1)